I am a urologic surgeon with expertise in minimally invasive techniques for the treatment of kidney, adrenal, and prostate cancers. Using laparoscopic, robotic, and image-guided therapies, the goal of our team is to provide appropriate curative therapeutic interventions through the organ-sparing approaches of less-invasive surgery. We are interested in the application and careful study of techniques such as robotic (da Vinci) prostatectomy, laparoscopic partial nephrectomy, partial adrenalectomy, cryo- and radiofrequency ablation, and MRI-guided prostate interventions using state-of-the-art instrumentation and imaging technology. We are also coupling these approaches with basic science research investigations of human cancers to discover optimal therapeutic strategies that can be tailored to each of our patients.
I have a special interest in patients with hereditary urologic cancer syndromes, including von Hipple-Lindau, Birt-Hogg-Dube, hereditary papillary kidney cancer, and hereditary leiomyomatosis and renal cell cancer.
- Clinical Expertise: Kidney, Adrenal, and Prostate Cancer Surgery using Laparoscopic, Robotic, and Minimally Invasive Techniques
- Languages Spoken: English
- Education: MD, Cornell University Medical College
- Residencies: General Surgery - New York Presbyterian Hospital; Urology - New York Presbyterian Hospital
- Fellowships: Urologic Oncology - National Cancer Institute
- Board Certifications: Urology
Selected Book Chapters
“Urologic emergencies.” Coleman JA, Walther MM. In: Cancer: Principles and Practice of Oncology. 7th ed. Devita VT Jr., Lawrence TS, Rosenberg SA, eds. Philadelphia: Lippincott Williams & Wilkins; 2005.
“Vaccine development.” Karanikolas N, Coleman J. In: Current Clinical Urology: Bladder Cancer. Lee CT, Wood DP, eds. Springer: New York; 2009.
“Laparoscopic transperitoneal radical nephrectomy.” Kimm, SY, Coleman JA. In: Atlas of Laparoscopic and Robotic Urologic Oncological Surgery. Philadelphia: Jaypee Brothers Medical Publishers; 2013.
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more